Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging

    The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition

    Published: July 29, 2021 | Price: $12,500 – $16,500

    Kalorama Information's latest edition of our in vitro diagnostic market report is available for sales.  This represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers.  Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined  This year, COVID-19 is to some degree a routine test category in respiratory and infectious disease testing, themselves high-growth segments.   Now the question will...
    The Market for In Vitro Diagnostic Tests in Latin America

    Published: June 29, 2021 | Price: $4,000 – $8,000

    Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities.   This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,...
    The World Market for Molecular Diagnostics Tests, 10th Edition (NGS, PCR, NAAT, ISH, TMA, Other)

    Published: June 17, 2021 | Price: $5,000 – $10,000

    Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...
    United States Market for In Vitro Diagnostic (IVD) Tests

    Published: June 7, 2021 | Price: $4,000 – $8,000

    The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...
    Clinical Laboratory Services Market, 6th Edition

    Published: June 8, 2021 | Price: $4,000 – $8,000

    Clinical Laboratory Services Market, 6th Edition, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth.  Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies.  Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia...
    The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition

    Published: April 13, 2021 | Price: $5,000 – $10,000

    By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually.  This should not be surprising.  Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing.  In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC  COVID-19 was stunning. Updated for COVID-19 Impacts In some segments, COVID-19 caused a contraction of the segment...
    At-Home Testing: COVID-19 Trends and Future Potential

    Published: April 15, 2021 | Price: $3,000 – $6,000

    This first edition report At-Home Testing: COVID-19 Trends and Future Potential provides an overview of trends and developments in the home testing industry for the pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. For the purpose of this report, Kalorama Information concludes that the accepted definition of a home or...
    The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)

    Published: March 23, 2021 | Price: $5,000 – $10,000

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This report focuses on diagnostics.  The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024,...
    2021 IVD Market Update and COVID-19 Impact

    Published: March 12, 2021 | Price: $3,000 – $6,000

    What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...
    COVID-19 Testing Update 2021: Molecular and Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends

    Published: February 16, 2021 | Price: $3,000 – $6,000

    As the unfortunate milestone of one full year of the global COVID-19 pandemic worldwide is reached, the diagnostic industry has been changed, perhaps permanently.  Hundreds of test products are on the market to detect the virus, both for its presence and immune response.  And billions of dollars have been added to the in vitro diagnostic market.  Companies have doubled and tripled revenues, bought new companies, increased manufacturing, shifted focus to infectious diseases and launched new products. "A 38 Billion Dollar Market...
    The Market and Potential for Molecular Point of Care 2021

    Published: January 22, 2021 | Price: $4,000 – $8,000

    This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...
    IVD Procedure Volumes 2020-2025: Immunoassays, POC, Chemistry, Molecular, Microbiology and Other Tests

    Published: February 23, 2021 | Price: $4,000 – $8,000

    In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business...
    Genetic Testing Markets for Epilepsy, Autism, Alzheimer’s and Other Neurologic Conditions

    Published: January 4, 2021 | Price: $4,000 – $8,000

    Genetic involvement in the pathogenesis of neurological disease is significant. Central nervous system disorders account for approximately 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases.  Neurological diseases, especially brain diseases, are the last frontier in medical discovery. Advances in testing such as next-generation sequencing have been instrumental in identifying genetic causes for neurological conditions. The area of inherited condition testing for neurological conditions has become a major area of activity in the last decade or so,...
    COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

    Published: November 2, 2020 | Price: $4,000 – $8,000

    COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000 – $6,000

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...